The Peptide Directory

Not approved (research only)NeuropeptideImmune / lung research

VIP (vasoactive intestinal peptide)

Vasoactive intestinal peptide (VIP) is a 28-amino-acid neuropeptide; synthetic VIP (aviptadil) has been studied in lung disease.

Last reviewed by The Peptide Directory Editorial Team

What is VIP?

Vasoactive intestinal peptide (VIP) is a 28-amino-acid neuropeptide; synthetic VIP (aviptadil) has been studied in lung disease. VIP (vasoactive intestinal peptide) is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.

Key takeaways

  1. VIP (vasoactive intestinal peptide) is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
  2. PubMed indexes 8,400 papers on VIP (110 tagged as clinical trials) as of October 19, 2026.
  3. ClinicalTrials.gov lists 20 registered studies using VIP.
  4. 23 vendors in our directory listed VIP in their public catalog on October 19, 2026.

Regulatory & access status

VIP (vasoactive intestinal peptide) is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.

Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.

How much research exists on VIP (vasoactive intestinal peptide)?

PubMed indexes 8,400 papers mentioning VIP (vasoactive intestinal peptide) in the title or abstract, 883 of them from the last five years and 110 tagged as clinical trials (search run October 19, 2026; repeat the search).

Most relevant recent papers

Registered clinical studies

ClinicalTrials.gov lists 20 studies with VIP (vasoactive intestinal peptide) as an intervention (see all). Most recent:

What the evidence does not show

  • Paper counts measure research attention, not whether VIP works or is safe.
  • No FDA review of any "research use only" product's identity, purity, sterility or dose.

Research suppliers that list VIP

23 vendors in our directory listed a product matching VIP in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.

Prices per mg, where we could verify them, are on our price comparison.

VIP reconstitution math

Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.

VIP FAQ

Is VIP FDA-approved?

VIP (vasoactive intestinal peptide) is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.

Is VIP safe?

Safety data come from the published studies listed on this page; read them in full. Products sold as "research use only" have no FDA review of their purity, sterility or dose.

How much research is there on VIP?

PubMed indexes 8,400 papers on VIP (110 tagged as clinical trials) as of October 19, 2026.

Who sells VIP?

Ascension Peptides, Atomik Labz, Biocollex Research, BioGenix Peptides, BioLongevity Labs, Biotech Peptides and 17 more listed it on their public catalogs when we checked; a listing is not an endorsement.

Related compounds

OxytocinLL-37CerebrolysinTB-500DSIPThymalinSemaxThymogenAll cognitive, neuro & sleepAll immune support